Insufficient scRNA-seq data for expression of IL26 at single-cell level.
Insufficient scRNA-seq data for expression of IL26 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
spleen | 92% | 7.90 | 222 / 241 | 0% | 0 | 0 / 0 |
intestine | 76% | 6.09 | 737 / 966 | 13% | 0.25 | 68 / 527 |
lung | 56% | 3.07 | 322 / 578 | 6% | 0.14 | 71 / 1155 |
stomach | 33% | 1.25 | 117 / 359 | 16% | 0.31 | 47 / 286 |
peripheral blood | 48% | 1.99 | 445 / 929 | 0% | 0 | 0 / 0 |
bladder | 38% | 1.57 | 8 / 21 | 7% | 0.16 | 33 / 504 |
esophagus | 28% | 2.87 | 403 / 1445 | 10% | 0.20 | 19 / 183 |
brain | 36% | 1.16 | 941 / 2642 | 1% | 0.05 | 4 / 705 |
prostate | 32% | 1.14 | 78 / 245 | 0% | 0.00 | 1 / 502 |
adipose | 31% | 0.97 | 376 / 1204 | 0% | 0 | 0 / 0 |
uterus | 22% | 0.45 | 37 / 170 | 5% | 0.28 | 23 / 459 |
blood vessel | 25% | 0.86 | 339 / 1335 | 0% | 0 | 0 / 0 |
thymus | 25% | 0.90 | 160 / 653 | 1% | 0.01 | 5 / 605 |
skin | 23% | 0.86 | 412 / 1809 | 1% | 0.01 | 5 / 472 |
breast | 20% | 0.56 | 91 / 459 | 1% | 0.02 | 15 / 1118 |
kidney | 20% | 0.64 | 18 / 89 | 1% | 0.01 | 6 / 901 |
lymph node | 0% | 0 | 0 / 0 | 21% | 0.30 | 6 / 29 |
liver | 19% | 0.47 | 44 / 226 | 0% | 0.01 | 2 / 406 |
heart | 20% | 1.18 | 171 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 18% | 0.27 | 8 / 45 |
ovary | 14% | 0.25 | 25 / 180 | 0% | 0.01 | 1 / 430 |
adrenal gland | 10% | 0.22 | 26 / 258 | 0% | 0.01 | 1 / 230 |
muscle | 8% | 0.20 | 66 / 803 | 0% | 0 | 0 / 0 |
pancreas | 6% | 0.12 | 21 / 328 | 2% | 0.02 | 3 / 178 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0001819 | Biological process | positive regulation of cytokine production |
GO_0032874 | Biological process | positive regulation of stress-activated MAPK cascade |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0046427 | Biological process | positive regulation of receptor signaling pathway via JAK-STAT |
GO_0050680 | Biological process | negative regulation of epithelial cell proliferation |
GO_0007267 | Biological process | cell-cell signaling |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005615 | Cellular component | extracellular space |
GO_0005829 | Cellular component | cytosol |
GO_0005576 | Cellular component | extracellular region |
GO_0005125 | Molecular function | cytokine activity |
Gene name | IL26 |
Protein name | Interleukin family protein Interleukin-26 (IL-26) (Protein AK155) |
Synonyms | hCG_1657416 IF2G AK155 |
Description | FUNCTION: May play a role in local mechanisms of mucosal immunity and seems to have a pro-inflammatory function. May play a role in inflammatory bowel disease. Activates STAT1 and STAT3, MAPK1/3 (ERK1/2), JUN and AKT. Induces expression of SOCS3, TNF-alpha and IL-8, secretion of IL-8 and IL-10 and surface expression of ICAM1. Decreases proliferation of intestinal epithelial cells. Is inhibited by heparin. . FUNCTION: Immune regulatory cytokine. . |
Accessions | A0A7R8GUW8 ENST00000229134.5 Q9NPH9 |